Maykin Ho

Maykin Ho, listed as board member, has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Kyntra Bio, Inc., Agios Pharmaceuticals, Inc. and Biomarin Pharmaceutical Inc. Between 15 September 2016 and 18 June 2026, the trades on record add up to 28 filings.

Sales make up the whole of the open-market record (2 sales, €138k). Other entries cover 17 share grants and 8 option exercises.

The latest filing, published on 23 June 2026, reports an option exercise in Agios Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.